Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Cash from Financing Activities (2018 - 2026)

TransMedics has reported Cash from Financing Activities over the past 8 years, most recently at $3.1 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 161.3% year-over-year to $3.1 million; the TTM value through Dec 2025 reached $16.9 million, down 26.3%, while the annual FY2025 figure was $16.9 million, 26.3% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was $3.1 million at TransMedics, down from $3.6 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $394.0 million in Q2 2023 and troughed at $45000.0 in Q4 2021.
  • A 5-year average of $30.5 million and a median of $3.0 million in 2022 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 99.72% in 2021 and later soared 166150.21% in 2023.
  • Year by year, Cash from Financing Activities stood at $45000.0 in 2021, then soared by 6711.11% to $3.1 million in 2022, then crashed by 69.85% to $924000.0 in 2023, then increased by 28.35% to $1.2 million in 2024, then surged by 161.3% to $3.1 million in 2025.
  • Business Quant data shows Cash from Financing Activities for TMDX at $3.1 million in Q4 2025, $3.6 million in Q3 2025, and $7.1 million in Q2 2025.